Disposable Asepsis Safe Injection Needle Market, By Needle Type Conventional and Safety Needles

Injection needles are most frequently used in medical procedures. According to the World Health Organization (WHO) 2012 data findings, every year at least 16 billion injections are being administered in emerging economies out of which, around 95% are given in curative care. Also, immunization accounts for around 3% of all the injections. Furthermore, according to the World Health Organization (WHO), nine out of 10 patients who visit a primary healthcare provider receive an injection. Moreover, unsafe injection practices cause severe infections, thereby causing severe risk of blood borne disease to the patients. Unsafe injection practices such as reuse of syringes and needles, improper or no sterilization of needles, and poor collection and disposal of dirty injection equipment leads to increasing adoption of disposable injection needles, thereby boosting growth of the disposable asepsis safe injection needle market.

Disposable Asepsis Safe Injection Needle Market Drivers

Increasing awareness regarding safe injection practices by healthcare regulatory organizations, in order to minimize the possible risk of infection related to blood-borne viruses (BBVs), will help in boosting the disposable asepsis safe injection needle market growth over the forecast period. For instance, according to the World Health Organization (WHO), in February 2012, unsafe injection led to an estimated 1.3 million early deaths, and an annual burden of US$ 535 million in direct medical costs every year. Moreover, unsafe injection practices are the most common cause of hepatitis C in emerging economies. Unsafe injection practices also leads to the transmission of blood borne pathogens, including hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).

Get The Holistic SAMPLE Of This Business Report:
https://www.coherentmarketinsights.com/insight/request-sample/1852

Increasing prevalence of certain disease conditions such as cancer, HIV/AIDS, diabetes, coronary heart disease, and anemia are driving growth of the disposable asepsis safe injection needle market. Furthermore, increasing number of surgeries and casualty cases, and high demand for blood transfusion are further offering lucrative growth opportunities in the market. According to the Centers for Disease Control and Prevention (CDC), the U.S. reported around 26,203 cases of Lyme disease between 2006 and 2016.

Moreover, the increasing demand for blood donations is also fuelling the demand for disposable asepsis safe injection needles. According to the World Health Organization (WHO), 112.5 million blood donations collected globally, every year and an increase of 10.7 million blood donations from unpaid donors was reported during 2008 to 2013. Furthermore, according to the American National Red Cross, around 7,000 units of platelets and 10,000 units of plasma are required daily in the U.S. and around 21 million blood components are transfused each year in the U.S.

Increasing demand for palliative care is a major factor that is expected to boost growth of the market. For instance, according to the World Health Organization (WHO), 2017, around 40 million people are in need of palliative care worldwide, of which 78% of the people live in low- and middle-income countries. Patients suffering from cardiovascular diseases (38.5%), cancer (34%), chronic respiratory diseases (10.3%), AIDS (5.7%), diabetes (4.6%), kidney failure, and chronic liver diseases require palliative care. Cardiovascular diseases, cancer, diabetes, and respiratory diseases are responsible for over 28 million deaths annually. Increasing number of surgeries and unmet surgical needs are expected to positively aid in growth of the market. For instance, according to World Bank statistics, in 2012, there were around 4,511 surgeries performed per 100,000 people, globally. As per Lancet Commission for Global Surgery report, in 2015, 28-32% of the global burden of diseases can be treated successfully through surgical intervention.

Introduction of stringent guidelines for safe injection practices is expected to boost growth of the disposable asepsis safe injection needle market size. For instance, organizations such as WHO and Association of Professionals in Infection Control and Epidemiology in the U.S. issued updated guidelines in 2016 to prevent spread of infectious diseases through unsafe injection practices.

Click To Reading More On
https://www.coherentmarketinsights.com/ongoing-insight/disposable-asepsis-safe-injection-needle-market-1852

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com
Visit our news Website:https://www.coherentwire.com

This release was published on openPR.